N-trifluoroacetyladriamycin

CAS No.: 26295-56-7

Chemical Name:: N-trifluoroacetyladriamycin

Synonyms: AD-41;NSC 283464;N-Trifluoroacetyldoxorubicin;(1S,3S)- α-2,3,6-trideoxy-3-(2,2,2-trifluoroacetaMido)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-Methoxy-6,11-dioxo-1-naphthacenyl L-lyxo-Hexopyranoside;(8S,10S)-7,8,9,10-Tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-[[3-(trifluoroacetylamino)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-6,8,11-trihydroxy-5,12-naphthacenedione;(8S-cis)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-Methoxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)aMino]-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-;2,2,2-Trifluoro-N-((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)acetamide (Doxorubicin Impurity)

CBNumber:: CB91398260

Molecular Formula:: C29H28F3NO12

Molecular Weight:: 639.53

MOL File:: 26295-56-7.mol

Modify Date:: 2023/4/23 13:52:06

Request For Quotation

N-trifluoroacetyladriamycin Properties

Melting point	>150°C (dec.)
Boiling point	855.4±65.0 °C(Predicted)
Density	1.66±0.1 g/cm3(Predicted)
solubility	DMSO, Methanol
pka	7.35±0.60(Predicted)
form	Solid
color	Red

SAFETY

Risk and Safety Statements

Toxicity	dnd-hmn-lym 1 mg/L CNREA8 39,448,1979

N-trifluoroacetyladriamycin Chemical Properties,Uses,Production

Chemical Properties

Red Solid

Uses

Doxorubicin (D558000) metabolite. Cytotoxic interaction with DNA.

Safety Profile

Mutation data reported. Whenheated to decomposition it emits toxic vapors of NOx andFí.

N-trifluoroacetyladriamycin Preparation Products And Raw materials

Raw materials

Preparation Products

N-trifluoroacetyladriamycin Suppliers

Global( 19)Suppliers

Supplier	Tel	Country	ProdList	Advantage	Inquiry
CLEARSYNTH LABS LTD.	+91-22-45045900	Hyderabad, India	6351	58	Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd	+91-172-5066494	Haryana, India	6773	58	Inquiry
Pharma Affiliates	172-5066494	Haryana, India	6761	58	Inquiry
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	United States	19892	58	Inquiry
Hangzhou MolCore BioPharmatech Co.,Ltd.	+86-057181025280; +8617767106207	China	49739	58	Inquiry
China National Standard Pharmaceutical Corporation Limited	+8615391658522	China	11927	58	Inquiry
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd	18502726233; 18502726233	China	9486	58	Inquiry
Shanghai Haohong Scientific Co., Ltd.	400-400-8210725	China	40041	58	Inquiry
Changzhou Bojia Biomedical Technology Co., Ltd.	2122619822	China	18488	58	Inquiry
CHEMICAL LAND21	82- 2 -783 - 8063	South Korea	6315	74	Inquiry

Supplier	Advantage
CLEARSYNTH LABS LTD.	58
Pharmaffiliates Analytics and Synthetics P. Ltd	58
Pharma Affiliates	58
TargetMol Chemicals Inc.	58
Hangzhou MolCore BioPharmatech Co.,Ltd.	58
China National Standard Pharmaceutical Corporation Limited	58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd	58
Shanghai Haohong Scientific Co., Ltd.	58
Changzhou Bojia Biomedical Technology Co., Ltd.	58
CHEMICAL LAND21	74

26295-56-7(N-trifluoroacetyladriamycin)Related Search:

Doxorubicinone Daunorubicin N-ETHYL-TETRAHYDRO-2H-PYRAN-4-AMINE Feudomycin A Medorubicin

Valrubicin 7-DEOXYDOXORUBICINONE 3-(TRIFLUOROACETYLAMINO)-1-PROPANOL Esorubicin 14-Hydroxy Carminomycin

N-trifluoroacetyladriamycin DAUNOMYCINONE 9-deoxydoxorubicin N-trifluoroacetyladriamycin-14-O-hemiadipate Adriamycin

Carubicin

chevron_left

1of4

chevron_right

(8S,10S)-7,8,9,10-Tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-[[3-(trifluoroacetylamino)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-6,8,11-trihydroxy-5,12-naphthacenedione AD-41 N-Trifluoroacetyldoxorubicin (1S,3S)- α-2,3,6-trideoxy-3-(2,2,2-trifluoroacetaMido)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-Methoxy-6,11-dioxo-1-naphthacenyl L-lyxo-Hexopyranoside (8S-cis)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-Methoxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)aMino]-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione NSC 283464 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)- 2,2,2-Trifluoro-N-((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)acetamide (Doxorubicin Impurity) 26295-56-7 C29H28F3NO12 Intermediates & Fine Chemicals Pharmaceuticals